Skip to main content
. 2013 Nov 5;9(5):858–864. doi: 10.5114/aoms.2013.38679

Table II.

Incidence (%) of AEs reported by ≥ 5% of patients in any group

Parameter Overall (n = 309) Newer (n = 76) Oldera (n = 233) Mono (n = 188) Poly (n = 121)
Neurological AE [%]
 Cognitive function disturbance 40.5 30.3 43.8** 31.4 54.5***
 Psychological problemsb 36.2 31.6 37.8 32.4 42.1
 Sedation 32.7 22.4 36.1** 28.2 39.7**
 Headache 18.4 12.0 13.6 14.4 12.4
 Tremor 13.6 9.2 15.0 8.5 21.5***
 Dizziness 10.4 6.6 11.6 8.0 14.0
 Ataxia 4.5 2.6 5.2 2.7 7.4**
 Dysarthria 3.6 6.6 2.6 0.5 8.3***
 Diplopia 3.2 6.6 2.1 1.6 5.8**
Systemic AE [%]
 Gain or loss of weight 19.4 15.8 20.6 19.7 19.0
 GI problems 12.0 2.6 15.0*** 8.5 15.4**
 Arthralgia 8.4 5.3 9.4 10.1 5.8
 Changes in hair quantity and texture 7.8 5.3 8.6 6.9 9.1
 Lack of menstrual cyclec 5.5 9.2 4.3 4.8 6.6
a

Also includes patients on 1 newer and 1 older AED

b

Depression, tension/agitation, anger/hostility, vigor/excitability, fatigue/apathy, confusion/thought disorder

c

If applicable

**

p < 0.05

***

p < 0.01